leprosy Flashcards
case
A 25-year-old man presented with a single, slowly expanding, nonpainful scaly lesion on his chest for the past 2 months.
* The lesion was nonpruritic, and he had lost sensation at the site of the lesion. He was otherwise well.
* He is a recent immigrant.
* An acid-fast stain of scraping of the lesion
was positive.
* Lepromin test was positive
Specimen Collection
Total six samples are collected; four from skin (forehead, cheek, chin and buttock), one from ear lobe and nasal mucosa by nasal blow/scraping.
Slit skin smear is the technique followed to collect the skin and ear lobe specimens. The edge of the lesion is the preferred site
Nasal specimens:
(1) Nasal blow: Early morning mucus material is collected by blowing the
patient’s nose on a clean cellophane sheet
(2) Nasal scraping: By using a mucosal scraper to scrape the nasal septum sufficiently to remove a piece of mucous membrane, which is transferred onto a slide and teased out into a uniform smear.
Biopsy from the thickened nerves and nodular lesions
microscopy
Ziehl–Neelsen - 5% sulfuric acid for decolorization: Red acid-fast bacilli, arranged singly or in groups (cigar like bundles), bound together by lipid-like substance, the glia to form globi. The globi are present inside the foamy macrophages called
Virchow’s lepra cells or foamy cells.
Grading of the Smear
The smears are graded, based on the number of bacilli per oil immersion field (OIF) as follows:
1–10 bacilli in 100 OIF =1+
1–10 bacilli in 10 OIF = 2+
1–10 bacilli per OIF = 3+
10–100 bacilli per OIF = 4+
100–1000 bacilli per OIF = 5+
>1000 bacilli or bacilli in clumps and globi in each OIF = 6+
Mouse Foot Pad Cultivation
The specimen can be inoculated into foot pad of mice and keep at 20°C for 6–9 months.
➢ Nine banded armadillo
Antibody Detection
➢ FLA-ABS (Fluorescent leprosy antibody absorption test
Detects M. leprae specific antibodies irrespective of duration and stage of the disease.
➢ ELISA detecting IgM antibodies to PGL-1 (phenolic glycolipid-1)
Test for Detecting CMI (Lepromin Test)
Demonstrates the delayed hypersensitivity reaction against the lepra antigen.
➢ It also indicates an intact host’s CMI.
➢ It is not used for diagnosis of active infection.
➢ It is useful in classifying lesions of leprosy and also used as a prognostic indicator.